Hype over Acomplia weight-loss drug not yet justified, researchers say

12/6/2004 | NYTimes.com

Medical researchers warn that in the absence of supporting studies, the current hype over Sanofi-Aventis' Acomplia as a miracle drug to help people get rid of fat, lead them to quit smoking and no longer need alcohol all at the same time is not justified. Researchers note the only information about Acomplia has come from the company, and it indicates the drug is no more effective than two other drugs, Meridia and Orlistat, already on the market. Sanofi has not even applied for FDA approval yet.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA